Sign in
4

Changes in Ownership

IONIS PHARMACEUTICALS INC Filed Acc 0000874015-26-000229

Director sold 11,518 shares at an average $79.04 ($910,416)

  • Director acquired 11,518 shares (option exercise)
  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

KLEIN JOSEPH III · Director

Table I: Non-derivative

3 lines
Date Transaction Shares Price Value Owned after D/I
2026-07-01 Exercise or conversion : show line 1 in the form 10b5-1 +11,518 $39.94 $460,029 22,532 D
2026-07-01 Sale : show line 2 in the form 10b5-1 −99 $79.45 $7,866 22,433 D
2026-07-01 Sale : show line 3 in the form 10b5-1 −11,419 $79.04 $902,551 11,014 D
Open-market sales · 11,518 sh · avg $79.04 · $910,416

Table II: Derivative

3 lines
Date Transaction Shares Owned after D/I
2026-07-01 Exercise or conversion : show line 4 in the form 10b5-1 Non-Qualified Stock Option (right to buy) −11,518 0 D
2026-07-01 Grant or award : show line 5 in the form 10b5-1 Non-Qualified Stock Option (right to buy) +5,369 5,369 D
2026-07-01 Grant or award : show line 6 in the form 10b5-1 Restricted Stock Unit +2,301 16,277 D
Loading xslF345X06/edgardoc.xml…